WallStSmart

Arcosa Inc (ACA)vsMasTec Inc (MTZ)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

MasTec Inc generates 396% more annual revenue ($14.30B vs $2.88B). ACA leads profitability with a 7.2% profit margin vs 2.8%. ACA appears more attractively valued with a PEG of 1.38. ACA earns a higher WallStSmart Score of 64/100 (C+).

ACA

Buy

64

out of 100

Grade: C+

Growth: 5.3Profit: 5.5Value: 10.0Quality: 7.0
Piotroski: 3/9Altman Z: 1.73

MTZ

Buy

58

out of 100

Grade: C

Growth: 8.7Profit: 5.5Value: 5.3Quality: 7.0
Piotroski: 4/9Altman Z: 2.59
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ACAUndervalued (+35.6%)

Margin of Safety

+35.6%

Fair Value

$198.43

Current Price

$106.72

$91.71 discount

UndervaluedFair: $198.43Overvalued
MTZOvervalued (-7.7%)

Margin of Safety

-7.7%

Fair Value

$246.17

Current Price

$323.55

$77.38 premium

UndervaluedFair: $246.17Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ACA1 strengths · Avg: 8.0/10
Price/BookValuation
2.0x8/10

Reasonable price relative to book value

MTZ2 strengths · Avg: 9.0/10
EPS GrowthGrowth
92.8%10/10

Earnings expanding 92.8% YoY

Revenue GrowthGrowth
15.8%8/10

15.8% revenue growth

Areas to Watch

ACA4 concerns · Avg: 3.5/10
EPS GrowthGrowth
3.4%4/10

3.4% earnings growth

Altman Z-ScoreHealth
1.734/10

Distress zone — elevated risk

Profit MarginProfitability
7.2%3/10

7.2% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

MTZ3 concerns · Avg: 3.0/10
PEG RatioValuation
1.964/10

Expensive relative to growth rate

Profit MarginProfitability
2.8%3/10

2.8% margin — thin

P/E RatioValuation
61.3x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : ACA

The strongest argument for ACA centers on Price/Book. PEG of 1.38 suggests the stock is reasonably priced for its growth.

Bull Case : MTZ

The strongest argument for MTZ centers on EPS Growth, Revenue Growth. Revenue growth of 15.8% demonstrates continued momentum.

Bear Case : ACA

The primary concerns for ACA are EPS Growth, Altman Z-Score, Profit Margin.

Bear Case : MTZ

The primary concerns for MTZ are PEG Ratio, Profit Margin, P/E Ratio. A P/E of 61.3x leaves little room for execution misses. Thin 2.8% margins leave little buffer for downturns.

Key Dynamics to Monitor

ACA profiles as a value stock while MTZ is a growth play — different risk/reward profiles.

MTZ carries more volatility with a beta of 1.89 — expect wider price swings.

MTZ is growing revenue faster at 15.8% — sustainability is the question.

MTZ generates stronger free cash flow (214M), providing more financial flexibility.

Bottom Line

ACA scores higher overall (64/100 vs 58/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Arcosa Inc

INDUSTRIALS · ENGINEERING & CONSTRUCTION · USA

Arcosa, Inc. provides infrastructure related products and solutions for the construction, energy and transportation markets in North America. The company is headquartered in Dallas, Texas.

Visit Website →

MasTec Inc

INDUSTRIALS · ENGINEERING & CONSTRUCTION · USA

MasTec, Inc., an infrastructure construction company, provides engineering, construction, installation, maintenance, and upgrade services for communications, energy, utilities, and other infrastructure primarily in the United States and Canada. The company is headquartered in Coral Gables, Florida.

Visit Website →

Want to dig deeper into these stocks?